33
Participants
Start Date
March 31, 2014
Primary Completion Date
June 28, 2018
Study Completion Date
July 6, 2020
octreotide
Octreotide 100mg subcutaneous every 8 hours for 5 days
No Octreotide
No drug
Florida Hospital, Orlando
Lead Sponsor
AdventHealth
OTHER